featured
Beta-Hydroxybutyrate Levels and the Risk of Diabetic Ketoacidosis in Adults With Type 1 Diabetes Treated With Sotagliflozin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin
Diabetes Technol. Ther. 2024 Sep 01;26(9)618-625, S Boeder, MJ Davies, JB McGill, R Pratley, M Girard, P Banks, J Pettus, S GargFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.